| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | dendrite | 6.71e-04 | 858 | 37 | 7 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 6.80e-04 | 860 | 37 | 7 | GO:0097447 | |
| Domain | PID | 1.32e-03 | 28 | 36 | 2 | PF00640 | |
| Domain | PID | 1.73e-03 | 32 | 36 | 2 | PS01179 | |
| Domain | Ig-like_fold | 2.11e-03 | 706 | 36 | 6 | IPR013783 | |
| Domain | PDZ | 2.51e-03 | 141 | 36 | 3 | PF00595 | |
| Domain | PTB | 2.69e-03 | 40 | 36 | 2 | SM00462 | |
| Domain | PTB/PI_dom | 2.83e-03 | 41 | 36 | 2 | IPR006020 | |
| Domain | PDZ | 2.87e-03 | 148 | 36 | 3 | SM00228 | |
| Domain | - | 2.99e-03 | 150 | 36 | 3 | 2.30.42.10 | |
| Domain | PDZ | 3.04e-03 | 151 | 36 | 3 | PS50106 | |
| Domain | PDZ | 3.10e-03 | 152 | 36 | 3 | IPR001478 | |
| Domain | ig | 5.78e-03 | 190 | 36 | 3 | PF00047 | |
| Domain | Immunoglobulin | 5.78e-03 | 190 | 36 | 3 | IPR013151 | |
| Domain | CH | 8.03e-03 | 70 | 36 | 2 | PF00307 | |
| Domain | - | 8.26e-03 | 71 | 36 | 2 | 1.10.418.10 | |
| Domain | - | 8.42e-03 | 663 | 36 | 5 | 2.60.40.10 | |
| Domain | IG | 8.48e-03 | 421 | 36 | 4 | SM00409 | |
| Domain | Ig_sub | 8.48e-03 | 421 | 36 | 4 | IPR003599 | |
| Domain | CH | 8.71e-03 | 73 | 36 | 2 | PS50021 | |
| Domain | IGv | 9.18e-03 | 75 | 36 | 2 | SM00406 | |
| Domain | CH-domain | 9.18e-03 | 75 | 36 | 2 | IPR001715 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.62e-04 | 56 | 27 | 3 | M27616 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 7678331 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 23437230 | ||
| Pubmed | The PTB domain: a new protein module implicated in signal transduction. | 1.10e-06 | 2 | 37 | 2 | 7545337 | |
| Pubmed | Early anti-angiogenic proteins expression in amniotic fluid of twin fetuses. | 1.10e-06 | 2 | 37 | 2 | 21962138 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 19350449 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9614075 | ||
| Pubmed | Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia. | 1.10e-06 | 2 | 37 | 2 | 23806447 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 16870672 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 18330824 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 28609171 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 19039203 | ||
| Pubmed | Expression and localization of X11 family proteins in neurons. | 1.10e-06 | 2 | 37 | 2 | 27268412 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 22264588 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 24217170 | ||
| Pubmed | Comparison of primary structure of a neuron-specific protein, X11, between human and mouse. | 1.10e-06 | 2 | 37 | 2 | 7719031 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 20199197 | ||
| Pubmed | Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia. | 1.10e-06 | 2 | 37 | 2 | 17210583 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 26159901 | ||
| Pubmed | Correlations among antiangiogenic factors and trace elements in hypertensive disorders of pregnancy. | 1.10e-06 | 2 | 37 | 2 | 25053574 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 18771978 | ||
| Pubmed | X11 and X11-like proteins regulate the level of extrasynaptic glutamate receptors. | 1.10e-06 | 2 | 37 | 2 | 30411795 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 12547917 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 25979720 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 28613009 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 27664209 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 19412349 | ||
| Pubmed | Maternal circulating angiogenic factors in twin and singleton pregnancies. | 3.30e-06 | 3 | 37 | 2 | 25434840 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 20948996 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 27793555 | ||
| Pubmed | Circulating angiogenic and antiangiogenic factors in women with eclampsia. | 3.30e-06 | 3 | 37 | 2 | 21062661 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 18175241 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 14970211 | ||
| Pubmed | Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery. | 3.30e-06 | 3 | 37 | 2 | 21939291 | |
| Pubmed | Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria. | 3.30e-06 | 3 | 37 | 2 | 19165674 | |
| Pubmed | Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy. | 3.30e-06 | 3 | 37 | 2 | 27067718 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 28121958 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 19135290 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 15699037 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 34697959 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 17956952 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 19118172 | ||
| Pubmed | A rare autism-associated MINT2/APBA2 mutation disrupts neurexin trafficking and synaptic function. | 6.60e-06 | 4 | 37 | 2 | 30988517 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 17167098 | ||
| Pubmed | X11 alpha and x11 beta interact with presenilin-1 via their PDZ domains. | 6.60e-06 | 4 | 37 | 2 | 11083918 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 18845544 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 20016085 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 9585438 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 24742670 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 21827221 | ||
| Pubmed | The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia. | 6.60e-06 | 4 | 37 | 2 | 30177039 | |
| Pubmed | Mints as adaptors. Direct binding to neurexins and recruitment of munc18. | 6.60e-06 | 4 | 37 | 2 | 11036064 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 27169826 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 24380505 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 21867402 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 12842896 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 9822620 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 15563604 | ||
| Pubmed | Mints, Munc18-interacting proteins in synaptic vesicle exocytosis. | 1.10e-05 | 5 | 37 | 2 | 9395480 | |
| Pubmed | 1.65e-05 | 6 | 37 | 2 | 38072052 | ||
| Pubmed | 1.65e-05 | 6 | 37 | 2 | 12196555 | ||
| Pubmed | Allelic variations in angiogenic pathway genes are associated with preeclampsia. | 1.65e-05 | 6 | 37 | 2 | 20223440 | |
| Pubmed | B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules. | 2.30e-05 | 7 | 37 | 2 | 11986954 | |
| Pubmed | Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. | 3.95e-05 | 9 | 37 | 2 | 20062062 | |
| Pubmed | Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. | 7.22e-05 | 12 | 37 | 2 | 10846156 | |
| Pubmed | Distinct Distribution of RTN1A in Immune Cells in Mouse Skin and Lymphoid Organs. | 8.53e-05 | 13 | 37 | 2 | 33542915 | |
| Pubmed | 1.15e-04 | 15 | 37 | 2 | 19087347 | ||
| Pubmed | Identification of Thymosin β4 as an effector of Hand1-mediated vascular development. | 1.15e-04 | 15 | 37 | 2 | 20975697 | |
| Pubmed | A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales. | 1.48e-04 | 17 | 37 | 2 | 22832960 | |
| Pubmed | Lymph sacs are not required for the initiation of lymph node formation. | 1.86e-04 | 19 | 37 | 2 | 19060331 | |
| Pubmed | 2.28e-04 | 21 | 37 | 2 | 23707896 | ||
| Pubmed | 4.09e-04 | 28 | 37 | 2 | 27965054 | ||
| Pubmed | Extra-embryonic vasculature development is regulated by the transcription factor HAND1. | 4.09e-04 | 28 | 37 | 2 | 15073150 | |
| Pubmed | Dosage-dependent requirement for mouse Vezf1 in vascular system development. | 4.39e-04 | 29 | 37 | 2 | 15882861 | |
| Pubmed | A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. | 6.05e-04 | 34 | 37 | 2 | 12577067 | |
| Pubmed | 9.19e-04 | 1084 | 37 | 6 | 11544199 | ||
| Pubmed | 9.67e-04 | 43 | 37 | 2 | 26839965 | ||
| Pubmed | Serum response factor is required for sprouting angiogenesis and vascular integrity. | 9.67e-04 | 43 | 37 | 2 | 18804439 | |
| Cytoband | 11q13.2 | 6.68e-04 | 47 | 37 | 2 | 11q13.2 | |
| GeneFamily | PDZ domain containing | 1.31e-03 | 152 | 26 | 3 | 1220 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.27e-03 | 394 | 26 | 4 | 471 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP | 7.97e-06 | 196 | 37 | 5 | M5256 | |
| Coexpression | MEISSNER_BRAIN_ICP_WITH_H3K4ME3 | 1.13e-05 | 31 | 37 | 3 | M1939 | |
| Coexpression | MEISSNER_ES_ICP_WITH_H3K4ME3 | 1.25e-05 | 32 | 37 | 3 | M1929 | |
| Coexpression | MEISSNER_BRAIN_ICP_WITH_H3K4ME3 | 1.25e-05 | 32 | 37 | 3 | MM823 | |
| Coexpression | MEISSNER_ES_ICP_WITH_H3K4ME3 | 1.37e-05 | 33 | 37 | 3 | MM815 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 1.52e-05 | 584 | 37 | 7 | M39068 | |
| Coexpression | BAKKER_FOXO3_TARGETS_UP | 6.82e-05 | 56 | 37 | 3 | MM903 | |
| Coexpression | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP | 8.69e-05 | 323 | 37 | 5 | M15107 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 1.24e-04 | 1102 | 37 | 8 | M2369 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 1.27e-04 | 1106 | 37 | 8 | M39071 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 1.42e-04 | 1124 | 37 | 8 | MM1070 | |
| Coexpression | GSE7831_1H_VS_4H_CPG_STIM_PDC_DN | 1.75e-04 | 199 | 37 | 4 | M6961 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN | 1.78e-04 | 200 | 37 | 4 | M5052 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 1.78e-04 | 200 | 37 | 4 | M6610 | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.95e-07 | 197 | 37 | 5 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.19e-06 | 155 | 37 | 4 | ab539c04f10276ae919d82b1c75f99a84eb695bf | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.19e-06 | 155 | 37 | 4 | 9a27558c457f05808af07190b7a5006b047f1d58 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 171 | 37 | 4 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.26e-05 | 173 | 37 | 4 | 71dc0051c87b84e3cf13cde8858166f2a474b5dc | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.26e-05 | 173 | 37 | 4 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.54e-05 | 182 | 37 | 4 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 1.57e-05 | 183 | 37 | 4 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-05 | 185 | 37 | 4 | f4588468e8654363f48adbe427dff10f16f1c7fe | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-05 | 185 | 37 | 4 | 3cb816fc9541c04b4436e21d984216cfbbacff98 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-05 | 185 | 37 | 4 | c2e70405969616c28fb6379ee318e17bbcef7b49 | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 1.68e-05 | 186 | 37 | 4 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-05 | 186 | 37 | 4 | b031f4e6867b6200b85f43276a34749bf5f4603f | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-05 | 186 | 37 | 4 | d2fbf53aac905c9896272ec5c2db28ee1a60f4be | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 1.68e-05 | 186 | 37 | 4 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-05 | 186 | 37 | 4 | 79aedd5aed72509a4925e9f6cb43bc0c798c86f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 37 | 4 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 37 | 4 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Mild_COVID-19-Myeloid-pDC|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.71e-05 | 187 | 37 | 4 | 99c3c4a7b9179dce7982dc6516d561c952abc80e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.75e-05 | 188 | 37 | 4 | 78e79b8e298aa77c8c01320bab4fb1a00f11a772 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 188 | 37 | 4 | ef3f6400c018834a8fd56893faa3476a0f10aedc | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.86e-05 | 191 | 37 | 4 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 1.90e-05 | 192 | 37 | 4 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.94e-05 | 193 | 37 | 4 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.94e-05 | 193 | 37 | 4 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.98e-05 | 194 | 37 | 4 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.98e-05 | 194 | 37 | 4 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 1.98e-05 | 194 | 37 | 4 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | 1.98e-05 | 194 | 37 | 4 | e6391bc7073831847c469ef0b0c437118e1f151f | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.02e-05 | 195 | 37 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.06e-05 | 196 | 37 | 4 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.06e-05 | 196 | 37 | 4 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 2.10e-05 | 197 | 37 | 4 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | Monocytes-cDCs|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 2.10e-05 | 197 | 37 | 4 | 15cb9fe1c3bab80bd24728fd9ac7ba385912ac33 | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 2.10e-05 | 197 | 37 | 4 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 198 | 37 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.14e-05 | 198 | 37 | 4 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 37 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.23e-05 | 200 | 37 | 4 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 37 | 4 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | (50)_cDC2|World / shred on Cell_type and subtype | 2.50e-05 | 206 | 37 | 4 | d519adeb8290fcce107e81a439ba3bf1e231b55b | |
| ToppCell | Dendritic_Cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.84e-05 | 100 | 37 | 3 | bb7bd11e28be830f381144d4a6f29a86da59d9fa | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-04 | 126 | 37 | 3 | 197d2c836ae46a5c67f68d10c71ba86b7b40b59d | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.03e-04 | 138 | 37 | 3 | c172880eda7b8b8b758dbbc77f93191238f3181c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.08e-04 | 139 | 37 | 3 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-04 | 139 | 37 | 3 | 313f7e66ed94950129c7146a2afe2feb8951fe1e | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.17e-04 | 141 | 37 | 3 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-9|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.50e-04 | 148 | 37 | 3 | 683b2b80ee389469d948aaf6a77632b24f56e989 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.65e-04 | 151 | 37 | 3 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.70e-04 | 152 | 37 | 3 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.91e-04 | 156 | 37 | 3 | 6c8f442ed94ae31e6832b68137e98ae78091ac6c | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.91e-04 | 156 | 37 | 3 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-04 | 156 | 37 | 3 | 0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 156 | 37 | 3 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-04 | 157 | 37 | 3 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.97e-04 | 157 | 37 | 3 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-04 | 157 | 37 | 3 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-04 | 157 | 37 | 3 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.97e-04 | 157 | 37 | 3 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.02e-04 | 158 | 37 | 3 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 3.08e-04 | 159 | 37 | 3 | 35a63ca521635389a1edc7c81157793b8ad24d38 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.08e-04 | 159 | 37 | 3 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 162 | 37 | 3 | ca30d9bf61f4133566fdc91c7996e130ea554d01 | |
| ToppCell | Dendritic_Cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-04 | 163 | 37 | 3 | 5fff3932c1c259010e3add7a3b2301df2fa37df1 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 163 | 37 | 3 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.31e-04 | 163 | 37 | 3 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 163 | 37 | 3 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-04 | 164 | 37 | 3 | 1592a5becad7e0f3f990f0d7581d75fcfc7da023 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-04 | 165 | 37 | 3 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-04 | 166 | 37 | 3 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.49e-04 | 166 | 37 | 3 | ce570b768988e30898cf0387c2aa99989631f13f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-04 | 167 | 37 | 3 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.56e-04 | 167 | 37 | 3 | ecdbfde870a2a44c44b9dd65a8737afc6fbf816c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 3.56e-04 | 167 | 37 | 3 | 0614d077b47a87f726068615548d0b0a216627be | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-04 | 168 | 37 | 3 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 168 | 37 | 3 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-04 | 168 | 37 | 3 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 168 | 37 | 3 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 168 | 37 | 3 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 169 | 37 | 3 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-04 | 169 | 37 | 3 | d4bd489ebdb86e70ed5e3dbbe8518c6cae2197e5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 169 | 37 | 3 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.68e-04 | 169 | 37 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 169 | 37 | 3 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-04 | 170 | 37 | 3 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 171 | 37 | 3 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 171 | 37 | 3 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.81e-04 | 171 | 37 | 3 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.81e-04 | 171 | 37 | 3 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 171 | 37 | 3 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 171 | 37 | 3 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 171 | 37 | 3 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 171 | 37 | 3 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 172 | 37 | 3 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 172 | 37 | 3 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 3.88e-04 | 172 | 37 | 3 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 3.88e-04 | 172 | 37 | 3 | 64928cea7e5b60e4bc4af016454b0173ebcc07c7 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 173 | 37 | 3 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 173 | 37 | 3 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-04 | 174 | 37 | 3 | 84da9faff088d05233183b425385beb054c92d1b | |
| Drug | AC1L4UUJ | 3.17e-06 | 18 | 37 | 3 | CID000164475 | |
| Drug | basic brown 1 | 1.54e-05 | 4 | 37 | 2 | CID000013981 | |
| Drug | tetramethyltin | 2.56e-05 | 5 | 37 | 2 | CID000011661 | |
| Drug | iBVE | 2.72e-05 | 36 | 37 | 3 | CID000007992 | |
| Disease | cancer antigen 125 measurement | 6.47e-05 | 10 | 36 | 2 | EFO_0010603 | |
| Disease | Primary microcephaly | 3.29e-04 | 22 | 36 | 2 | C0431350 | |
| Disease | retinal vasculature measurement | 3.90e-04 | 517 | 36 | 5 | EFO_0010554 | |
| Disease | temperament and character inventory | 3.93e-04 | 24 | 36 | 2 | EFO_0004825 | |
| Disease | intelligence, self reported educational attainment | 3.94e-04 | 117 | 36 | 3 | EFO_0004337, EFO_0004784 | |
| Disease | antipsychotic drug related weight gain | 4.98e-04 | 27 | 36 | 2 | EFO_0004567 | |
| Disease | FEV/FEC ratio | 6.15e-04 | 1228 | 36 | 7 | EFO_0004713 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.09e-03 | 447 | 36 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | pre-eclampsia (is_marker_for) | 2.29e-03 | 58 | 36 | 2 | DOID:10591 (is_marker_for) | |
| Disease | response to cranial radiation therapy, short-term memory | 2.45e-03 | 60 | 36 | 2 | EFO_0004335, EFO_0010950 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.78e-03 | 64 | 36 | 2 | DOID:4947 (is_marker_for) | |
| Disease | pentachlorophenol measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022071 | |
| Disease | parathion measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022053 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKPIRLLGSTIPLCS | 291 | P50416 | |
| IVSCPPVTTVLIKRP | 651 | Q99767 | |
| IPKTGTLSCTVALRP | 541 | P17813 | |
| VPLGKVVSTLPSTVL | 396 | Q9UKD1 | |
| PVTSLILPGLVKTTE | 9756 | Q8WXI7 | |
| VTLTCLATGKPEPSI | 156 | Q7Z3B1 | |
| ATVEKLPITSLGCPL | 56 | Q96EF0 | |
| PVTTLLPSIKCTGPL | 676 | Q13191 | |
| ILSPSRKVVPCLVTP | 981 | O75369 | |
| VVVTAIRGKSVCPPT | 1056 | Q12986 | |
| PTTVQTIVKRCGLPS | 701 | O43896 | |
| RKSLGTPTVICTPTE | 1006 | Q8NG31 | |
| LPSRISVIKGKCTVP | 186 | Q9Y4A0 | |
| ADILTPIISLTGPKC | 1161 | Q5VYJ5 | |
| APISKDRTICTVPLI | 316 | Q86SF2 | |
| IKETCRLIPAVPSIS | 371 | Q8N118 | |
| TTICPVVLQTLPTSG | 371 | Q9Y6T7 | |
| KLNIVRCPPVTTVLI | 736 | Q02410 | |
| KVVSVLPRALSLSCP | 291 | Q96MH7 | |
| LRLTLVVKVSTCVPG | 296 | Q8NFT8 | |
| KTTEIPLIGLIPSCQ | 126 | Q6ZTR5 | |
| TLGIITTVSILCPPK | 261 | Q8N465 | |
| ICLKPSPDTVPTVTV | 306 | Q16799 | |
| PLITNIIGILTICTK | 1711 | Q86VV8 | |
| LSVPVTLSSRILPVC | 131 | Q9NRR2 | |
| IPVIISPLKTISASL | 236 | P27930 | |
| IPCKVFLGTGTPLTT | 256 | P27930 | |
| TCSIPIPTIIVKEPS | 1026 | Q9UPX8 | |
| TLHCTVTSLIPVGPI | 51 | Q5TFQ8 | |
| PGKTPTVRAALICLT | 36 | Q9UJ71 | |
| ETSIPCTTLIPTKIP | 251 | Q17RW2 | |
| TTIPKCIFTALPLVT | 236 | Q8TCU3 | |
| CVSSLPGKLLSPQTI | 151 | Q86TA4 | |
| VGKPLVSVPLLITTS | 501 | Q6ZMS4 | |
| KPIPTCISSATGLIE | 291 | Q92558 | |
| GVILSISCLLKTPGV | 331 | Q14139 | |
| LVSVIRTTPIKPTCG | 31 | Q7RTV3 | |
| IPCRVTSPNITVTLK | 156 | P17948 | |
| CPLVVLPSLTEKVSL | 2076 | P01266 |